New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
How the current FDA AI/ML device regulations may be impeding innovation in the clinical lab
Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.
The recently proposed TCET rule appears to be too stringent to significantly hasten the Medicare coverage process for device makers.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.